Kageyama K, Tozawa F, Horiba N, Watanobe H, Suda T
Third Department of Internal Medicine, Hirosaki University School of Medicine, Aomori, Japan.
Neurosci Lett. 1998 Feb 27;243(1-3):17-20. doi: 10.1016/s0304-3940(98)00097-4.
To examine the direct effects of serotonin (5-HT) on the release and synthesis of corticotropin-releasing factor (CRF) in the hypothalamic paraventricular nucleus (PVN), 5-HT was microinjected just onto the bilateral PVN of conscious rats. Plasma adrenocorticotropic hormone (ACTH) levels peaked at 30 min and returned to the basal levels in 90 min. Northern blot analysis revealed that the CRF messenger RNA (mRNA) level in the PVN as well as the proopiomelanocortin mRNA level in the anterior pituitary significantly increased 120 min after the 5-HT injections (50-250 nmol/side). Pretreatment with intracerebroventricular (i.c.v.) injection of pindobind 5-HT1A (5 nmol) or LY-278584 (500 nmol) completely abolished the 5-HT-induced ACTH response, whereas LY-53857 (100 nmol) was without effect. These results suggest that 5-HT stimulates CRF release, which has interactions with 5-HT1A and 5-HT3 receptors on CRF neurons in the PVN, and activates CRF synthesis in conscious rats.
为研究血清素(5-羟色胺,5-HT)对下丘脑室旁核(PVN)中促肾上腺皮质激素释放因子(CRF)释放及合成的直接作用,将5-HT微量注射到清醒大鼠双侧PVN上。血浆促肾上腺皮质激素(ACTH)水平在30分钟时达到峰值,并在90分钟时恢复到基础水平。Northern印迹分析显示,在注射5-HT(50 - 250 nmol/侧)120分钟后,PVN中的CRF信使核糖核酸(mRNA)水平以及垂体前叶中的阿黑皮素原mRNA水平显著升高。脑室内(i.c.v.)注射5-HT1A拮抗剂哌哚宾(5 nmol)或5-HT3拮抗剂LY - 278584(500 nmol)预处理可完全消除5-HT诱导的ACTH反应,而5-HT4拮抗剂LY - 53857(100 nmol)则无此作用。这些结果表明,5-HT刺激CRF释放,这与PVN中CRF神经元上的5-HT1A和5-HT3受体相互作用,并激活清醒大鼠的CRF合成。